Dr. Richard Graham
Advertisement
Dr. Richard Graham is chairman of the board at Tru Technologies.
Articles by Dr. Richard Graham
Dr. Richard Graham discusses the distinction between real-time data and real-time oversite and how one option may present better results than the other.
Dr. Richard Graham details how real-time data review may reduce timelines but also allow for bad data or outcomes.
Dr. Richard Graham explains how FDA’s new program allows for the usage of real-time data during clinical trials.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
3
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
4
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
5